Answers are grounded in this paper and cite their sources.
Foxp3⁺ regulatory T cells (Tregs) represent a major fraction of skin resident T cells. Although normally protective, Tregs have been shown to produce pro-inflammatory cytokines in human diseases, including psoriasis. A significant hurdle in the Treg field has been the identification, or development, of model systems to study this Treg plasticity. To overcome this gap, we analyzed skin resident Tregs in a mouse model of IL-23 mediated psoriasiform dermatitis. Our results demonstrate that IL-23 drove the accumulation of Tregs; including a subpopulation that co-expressed RORγt and produced IL-17A. Genesis of this population was attenuated by a RORγt inverse agonist compound and clinically relevant therapeutics. In vitro, IL-23 drove the generation of CD4⁺Foxp3⁺RORγt⁺IL-17A⁺ cells from Treg cells. Collectively, our data shows that IL-23 drives Treg plasticity by inducing a population of CD4⁺Foxp3⁺RORγt⁺IL-17A⁺ cells that could play a role in the disease pathogenesis. Through this work, we define an in vitro system and a pre-clinical in vivo mouse model that can be used to further study Treg homeostasis and plasticity in the context of psoriasis.
No takes yet. Share an insight, caveat, or question.
Kannan et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: